HYOGO, Japan–(BUSINESS WIRE)–JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, announced today that it will present new clinical data in a poster session at the 18th International Symposium on MPS and Related Lysosomal Diseases, being held June 4-7 in Florence, Italy. The poster presentation will demonstrate the potential benefits of the investigational therapy,…
more
Source www.businesswire.com
Terms of use and third-party services. More here.
